D. E. Shaw & Co., Inc. Durect Corp Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $10,033 - $16,898	-26,404 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.55 - $0.98 $14,522 - $25,875	26,404 New	26,404 $18,000
Q1 2021 May 17, 2021	SELL	$1.86 - $2.87 $72,279 - $111,528	-38,860 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.65 - $2.43 $64,119 - $94,429	38,860 New	38,860 $80,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $223M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.